User login
From Hospital Admission to Home: New Standards for Extended Duration VTE Prophylaxis in Acutely Ill Medical Patients
Sunday, April 8
5:30 – 7:30 p.m., Canary Room 1-2
Dinner provided at 5:30 p.m.
Learning Objective: To educate on the risk of VTE in acutely ill medical patients, APEX clinical trial results, and Bevyxxa (betrixaban).
Overview:
- Review the burden of VTE in acutely ill medical patients.
- Provide an overview of the unmet need for extended-duration VTE prophylaxis from hospital admission to home.
- Review the APEX clinical trial data.
- Provide an overview of Bevyxxa (betrixaban) indication, safety information, dosing, and appropriate patient types.
Presenter: Hameed Ali, DO, FHM, clinical assistant professor of medicine and hospitalist, Baylor Scott and White Health Hospital, Temple, Tex.
This program is supported by Portola Pharmaceuticals.
Reducing COPD-related Readmissions through Individualized Maintenance Therapy and Increased Patient Engagement
Sunday, April 8
5:30 – 7:30 p.m., Canary Room 3-4
Dinner provided at 5:30 p.m.
Overview: Hospitals are a critical point of intervention in the care pathway of chronic obstructive pulmonary disease (COPD). Clinicians in this setting must be well versed in current treatment guidelines, as well as the full spectrum of medications and delivery devices, to provide disease management tailored to the physical and cognitive needs of each patient. Moreover, hospital clinicians also need to be adept at communicating with patients and engaging them in the management of their own disease. Collectively, these measures can significantly reduce symptom severity and the risk for future exacerbations, increase physical activity, and improve overall quality of life in patients with COPD. This program will improve the knowledge and competence of clinicians who care for patients with COPD.
Learning objectives: Upon completion of this educational activity, participants should be able to:
- Identify long-term treatment strategies to reduce hospital readmissions for COPD exacerbations.
- Review the clinical evidence regarding the efficacy and safety of long-acting maintenance regimens for COPD.
- Select medication delivery devices for patients with COPD based upon individual physical and cognitive characteristics.
- Outline a transitional care plan that promotes patient self-management to reduce the risk for future exacerbations and hospital readmissions.
Presenters: Stanley B. Fiel, MD, regional chair in the department of medicine, Atlantic Health System, and the deNeufville Professor, chairman of the department of medicine, Morristown (NJ) Medical Center; José Luis González, MD, assistant professor of internal medicine, department of internal medicine, University of Southern California, and primary care physician, department of primary care, LAC+USC Medical Center, Los Angeles.
Accreditation statement: Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit designation: Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A Physician’s Keys to Locking Out Lawsuits and Reducing Taxes
Monday, April 9
Noon – 1:00 p.m., Anaheim/Atlanta/Boston Room
Lunch provided at noon.
Objectives:
- Protect your license from negative reports to the National Practitioner Data Bank (NPDB) following a settlement from your insurance company. If there is no NPDB report, it’s unlikely that a board investigation into the legal matter will materialize. Preventing any sanctions from the state licensing board.
- Show how to structure: C-corps, S-corps, FLPs, LLCs, etc.
- Teach the use of legal tools that will protect their professional and personal assets from lawsuits. (Statistically, not even 1 in 100,000 are using these tools in the right way.)
- Learn how to protect business, property, and personal assets in the event of a judgment in excess of liability insurance.
- Learn how to protect your license from negative reports to the NPDB following a settlement from your insurance company. If there is no NPDB report, it’s unlikely that a board investigation into the legal matter will materialize. Preventing any sanctions from the state licensing board.
- Learn the best business structure for income tax reduction. Learn the new tax laws passed in 2017 and how they can benefit you.
Faculty: Art McOmber
Sponsored by Legally Mine.
Community-Acquired Bacterial Pneumonia (CABP) in the Hospital Setting: Why Are Patients Not Getting Better?
Monday, April 9
7:30 – 9:30 p.m., Canary Room 1-2
Dinner provided at 7:30 p.m.
Program Summary: Appropriate management of pneumonia in the hospital setting can have a substantial impact on patient outcomes and hospital measures such as readmission rates and length of stay. Community-acquired bacterial pneumonia (CABP) is one of the most common infectious diseases, one of the most frequent infections requiring antibiotics, and remains a leading cause of death in the United States. During this presentation, we will review current CABP guidelines from IDSA (the Infectious Diseases Society of America) and discuss the importance of appropriate antibiotic selection as it relates to the tenets of antimicrobial stewardship. The faculty will present two case studies and will solicit audience participation with a focus on antibiotic resistance and the importance of transition of care.
Chair: William Ford, MD, SFHM, Abington Jefferson Health, Abington, Penn.
Faculty: Mauricio Pinto, MD, St. David’s Round Rock Medical Center, Round Rock, Tex.; Sumeet Shetty, MD, MBA, FHM, Axel Health, Fort Meyers, Fla.
This program is supported by Nabriva Therapeutics, plc.
Register: NabrivaEvents@HCAGroup.com www.nabrivaevents.com/SHM/Symposium, or call 877-547-5640.
Direct Oral Anticoagulants (DOACs): Current Evidence for Extended VTE Prophylaxis in Medically Ill Patients and Reversal
Monday, April 9
7:30 – 9:30 p.m., Canary Room 3-4
Dinner provided at 7:30 p.m.
Overview: Patients hospitalized for an acute medical illness are at an increased risk for venous thromboembolism (VTE). With increasingly shortened hospital stays, acutely ill hospitalized patients are at an increased risk of developing VTE both in the hospital and after discharge. Outpatient VTE episodes often occur within 30 days of hospital discharge and fewer than half of those discharged patients receive VTE prophylaxis. Therefore, it is important for clinicians to be able to risk-stratify patients and provide extended prophylaxis for medical patients at increased risk for VTE.
This symposium will discuss the risk factors and burden of VTE and review ACCP guideline recommendations for VTE prophylaxis in acutely ill hospitalized medical patients. Faculty will assess the safety and efficacy of direct oral anticoagulants (DOACs) for extended VTE prophylaxis, explain the stratification of VTE and bleeding risk, as well as the process for devising evidence-based antithrombotic regimens. The presentation also will include an outline of current and emerging options for reversal of direct oral anticoagulants.
Learning objectives:
- Outline the risk factors and burden of VTE in medically ill patients post hospitalization.
- Review ACCP and ASH guideline recommendations for VTE prophylaxis in acutely ill hospitalized medical patients.
- Assess the safety and efficacy of DOACs for extended VTE prophylaxis in medically ill patients.
- Devise evidence-based antithrombotic regimens for medically ill patients taking into consideration patient-specific factors that impact VTE and bleeding risk
- Outline current and emerging options for reversal of DOACs
Faculty: Amir K. Jaffer, MD, MBA, chief medical officer, New York Presbyterian Queens Hospital, New York; Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC, professor of medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, system director – anticoagulation and clinical thrombosis services, Northwell Health at Lenox Hill Hospital, New York, NY; and Alan Jacobson, MD, FACC, assistant professor of medicine, Loma Linda University School of Medicine, director of anticoagulation services, Loma Linda VA Medical Center, Calif.
Target audience: Hospitalists, internists, nurse practitioners (NPs), physician assistants (PAs) who practice in a hospital setting.
Credit designation: Horizon CME designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the providership of Horizon CME. Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
ABIM MOC statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.
Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Supporter statement: This activity is supported by an independent educational grant from Portola Pharmaceuticals.
Register: http://bit.ly/2EoP1tb
From Hospital Admission to Home: New Standards for Extended Duration VTE Prophylaxis in Acutely Ill Medical Patients
Sunday, April 8
5:30 – 7:30 p.m., Canary Room 1-2
Dinner provided at 5:30 p.m.
Learning Objective: To educate on the risk of VTE in acutely ill medical patients, APEX clinical trial results, and Bevyxxa (betrixaban).
Overview:
- Review the burden of VTE in acutely ill medical patients.
- Provide an overview of the unmet need for extended-duration VTE prophylaxis from hospital admission to home.
- Review the APEX clinical trial data.
- Provide an overview of Bevyxxa (betrixaban) indication, safety information, dosing, and appropriate patient types.
Presenter: Hameed Ali, DO, FHM, clinical assistant professor of medicine and hospitalist, Baylor Scott and White Health Hospital, Temple, Tex.
This program is supported by Portola Pharmaceuticals.
Reducing COPD-related Readmissions through Individualized Maintenance Therapy and Increased Patient Engagement
Sunday, April 8
5:30 – 7:30 p.m., Canary Room 3-4
Dinner provided at 5:30 p.m.
Overview: Hospitals are a critical point of intervention in the care pathway of chronic obstructive pulmonary disease (COPD). Clinicians in this setting must be well versed in current treatment guidelines, as well as the full spectrum of medications and delivery devices, to provide disease management tailored to the physical and cognitive needs of each patient. Moreover, hospital clinicians also need to be adept at communicating with patients and engaging them in the management of their own disease. Collectively, these measures can significantly reduce symptom severity and the risk for future exacerbations, increase physical activity, and improve overall quality of life in patients with COPD. This program will improve the knowledge and competence of clinicians who care for patients with COPD.
Learning objectives: Upon completion of this educational activity, participants should be able to:
- Identify long-term treatment strategies to reduce hospital readmissions for COPD exacerbations.
- Review the clinical evidence regarding the efficacy and safety of long-acting maintenance regimens for COPD.
- Select medication delivery devices for patients with COPD based upon individual physical and cognitive characteristics.
- Outline a transitional care plan that promotes patient self-management to reduce the risk for future exacerbations and hospital readmissions.
Presenters: Stanley B. Fiel, MD, regional chair in the department of medicine, Atlantic Health System, and the deNeufville Professor, chairman of the department of medicine, Morristown (NJ) Medical Center; José Luis González, MD, assistant professor of internal medicine, department of internal medicine, University of Southern California, and primary care physician, department of primary care, LAC+USC Medical Center, Los Angeles.
Accreditation statement: Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit designation: Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A Physician’s Keys to Locking Out Lawsuits and Reducing Taxes
Monday, April 9
Noon – 1:00 p.m., Anaheim/Atlanta/Boston Room
Lunch provided at noon.
Objectives:
- Protect your license from negative reports to the National Practitioner Data Bank (NPDB) following a settlement from your insurance company. If there is no NPDB report, it’s unlikely that a board investigation into the legal matter will materialize. Preventing any sanctions from the state licensing board.
- Show how to structure: C-corps, S-corps, FLPs, LLCs, etc.
- Teach the use of legal tools that will protect their professional and personal assets from lawsuits. (Statistically, not even 1 in 100,000 are using these tools in the right way.)
- Learn how to protect business, property, and personal assets in the event of a judgment in excess of liability insurance.
- Learn how to protect your license from negative reports to the NPDB following a settlement from your insurance company. If there is no NPDB report, it’s unlikely that a board investigation into the legal matter will materialize. Preventing any sanctions from the state licensing board.
- Learn the best business structure for income tax reduction. Learn the new tax laws passed in 2017 and how they can benefit you.
Faculty: Art McOmber
Sponsored by Legally Mine.
Community-Acquired Bacterial Pneumonia (CABP) in the Hospital Setting: Why Are Patients Not Getting Better?
Monday, April 9
7:30 – 9:30 p.m., Canary Room 1-2
Dinner provided at 7:30 p.m.
Program Summary: Appropriate management of pneumonia in the hospital setting can have a substantial impact on patient outcomes and hospital measures such as readmission rates and length of stay. Community-acquired bacterial pneumonia (CABP) is one of the most common infectious diseases, one of the most frequent infections requiring antibiotics, and remains a leading cause of death in the United States. During this presentation, we will review current CABP guidelines from IDSA (the Infectious Diseases Society of America) and discuss the importance of appropriate antibiotic selection as it relates to the tenets of antimicrobial stewardship. The faculty will present two case studies and will solicit audience participation with a focus on antibiotic resistance and the importance of transition of care.
Chair: William Ford, MD, SFHM, Abington Jefferson Health, Abington, Penn.
Faculty: Mauricio Pinto, MD, St. David’s Round Rock Medical Center, Round Rock, Tex.; Sumeet Shetty, MD, MBA, FHM, Axel Health, Fort Meyers, Fla.
This program is supported by Nabriva Therapeutics, plc.
Register: NabrivaEvents@HCAGroup.com www.nabrivaevents.com/SHM/Symposium, or call 877-547-5640.
Direct Oral Anticoagulants (DOACs): Current Evidence for Extended VTE Prophylaxis in Medically Ill Patients and Reversal
Monday, April 9
7:30 – 9:30 p.m., Canary Room 3-4
Dinner provided at 7:30 p.m.
Overview: Patients hospitalized for an acute medical illness are at an increased risk for venous thromboembolism (VTE). With increasingly shortened hospital stays, acutely ill hospitalized patients are at an increased risk of developing VTE both in the hospital and after discharge. Outpatient VTE episodes often occur within 30 days of hospital discharge and fewer than half of those discharged patients receive VTE prophylaxis. Therefore, it is important for clinicians to be able to risk-stratify patients and provide extended prophylaxis for medical patients at increased risk for VTE.
This symposium will discuss the risk factors and burden of VTE and review ACCP guideline recommendations for VTE prophylaxis in acutely ill hospitalized medical patients. Faculty will assess the safety and efficacy of direct oral anticoagulants (DOACs) for extended VTE prophylaxis, explain the stratification of VTE and bleeding risk, as well as the process for devising evidence-based antithrombotic regimens. The presentation also will include an outline of current and emerging options for reversal of direct oral anticoagulants.
Learning objectives:
- Outline the risk factors and burden of VTE in medically ill patients post hospitalization.
- Review ACCP and ASH guideline recommendations for VTE prophylaxis in acutely ill hospitalized medical patients.
- Assess the safety and efficacy of DOACs for extended VTE prophylaxis in medically ill patients.
- Devise evidence-based antithrombotic regimens for medically ill patients taking into consideration patient-specific factors that impact VTE and bleeding risk
- Outline current and emerging options for reversal of DOACs
Faculty: Amir K. Jaffer, MD, MBA, chief medical officer, New York Presbyterian Queens Hospital, New York; Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC, professor of medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, system director – anticoagulation and clinical thrombosis services, Northwell Health at Lenox Hill Hospital, New York, NY; and Alan Jacobson, MD, FACC, assistant professor of medicine, Loma Linda University School of Medicine, director of anticoagulation services, Loma Linda VA Medical Center, Calif.
Target audience: Hospitalists, internists, nurse practitioners (NPs), physician assistants (PAs) who practice in a hospital setting.
Credit designation: Horizon CME designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the providership of Horizon CME. Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
ABIM MOC statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.
Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Supporter statement: This activity is supported by an independent educational grant from Portola Pharmaceuticals.
Register: http://bit.ly/2EoP1tb
From Hospital Admission to Home: New Standards for Extended Duration VTE Prophylaxis in Acutely Ill Medical Patients
Sunday, April 8
5:30 – 7:30 p.m., Canary Room 1-2
Dinner provided at 5:30 p.m.
Learning Objective: To educate on the risk of VTE in acutely ill medical patients, APEX clinical trial results, and Bevyxxa (betrixaban).
Overview:
- Review the burden of VTE in acutely ill medical patients.
- Provide an overview of the unmet need for extended-duration VTE prophylaxis from hospital admission to home.
- Review the APEX clinical trial data.
- Provide an overview of Bevyxxa (betrixaban) indication, safety information, dosing, and appropriate patient types.
Presenter: Hameed Ali, DO, FHM, clinical assistant professor of medicine and hospitalist, Baylor Scott and White Health Hospital, Temple, Tex.
This program is supported by Portola Pharmaceuticals.
Reducing COPD-related Readmissions through Individualized Maintenance Therapy and Increased Patient Engagement
Sunday, April 8
5:30 – 7:30 p.m., Canary Room 3-4
Dinner provided at 5:30 p.m.
Overview: Hospitals are a critical point of intervention in the care pathway of chronic obstructive pulmonary disease (COPD). Clinicians in this setting must be well versed in current treatment guidelines, as well as the full spectrum of medications and delivery devices, to provide disease management tailored to the physical and cognitive needs of each patient. Moreover, hospital clinicians also need to be adept at communicating with patients and engaging them in the management of their own disease. Collectively, these measures can significantly reduce symptom severity and the risk for future exacerbations, increase physical activity, and improve overall quality of life in patients with COPD. This program will improve the knowledge and competence of clinicians who care for patients with COPD.
Learning objectives: Upon completion of this educational activity, participants should be able to:
- Identify long-term treatment strategies to reduce hospital readmissions for COPD exacerbations.
- Review the clinical evidence regarding the efficacy and safety of long-acting maintenance regimens for COPD.
- Select medication delivery devices for patients with COPD based upon individual physical and cognitive characteristics.
- Outline a transitional care plan that promotes patient self-management to reduce the risk for future exacerbations and hospital readmissions.
Presenters: Stanley B. Fiel, MD, regional chair in the department of medicine, Atlantic Health System, and the deNeufville Professor, chairman of the department of medicine, Morristown (NJ) Medical Center; José Luis González, MD, assistant professor of internal medicine, department of internal medicine, University of Southern California, and primary care physician, department of primary care, LAC+USC Medical Center, Los Angeles.
Accreditation statement: Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit designation: Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A Physician’s Keys to Locking Out Lawsuits and Reducing Taxes
Monday, April 9
Noon – 1:00 p.m., Anaheim/Atlanta/Boston Room
Lunch provided at noon.
Objectives:
- Protect your license from negative reports to the National Practitioner Data Bank (NPDB) following a settlement from your insurance company. If there is no NPDB report, it’s unlikely that a board investigation into the legal matter will materialize. Preventing any sanctions from the state licensing board.
- Show how to structure: C-corps, S-corps, FLPs, LLCs, etc.
- Teach the use of legal tools that will protect their professional and personal assets from lawsuits. (Statistically, not even 1 in 100,000 are using these tools in the right way.)
- Learn how to protect business, property, and personal assets in the event of a judgment in excess of liability insurance.
- Learn how to protect your license from negative reports to the NPDB following a settlement from your insurance company. If there is no NPDB report, it’s unlikely that a board investigation into the legal matter will materialize. Preventing any sanctions from the state licensing board.
- Learn the best business structure for income tax reduction. Learn the new tax laws passed in 2017 and how they can benefit you.
Faculty: Art McOmber
Sponsored by Legally Mine.
Community-Acquired Bacterial Pneumonia (CABP) in the Hospital Setting: Why Are Patients Not Getting Better?
Monday, April 9
7:30 – 9:30 p.m., Canary Room 1-2
Dinner provided at 7:30 p.m.
Program Summary: Appropriate management of pneumonia in the hospital setting can have a substantial impact on patient outcomes and hospital measures such as readmission rates and length of stay. Community-acquired bacterial pneumonia (CABP) is one of the most common infectious diseases, one of the most frequent infections requiring antibiotics, and remains a leading cause of death in the United States. During this presentation, we will review current CABP guidelines from IDSA (the Infectious Diseases Society of America) and discuss the importance of appropriate antibiotic selection as it relates to the tenets of antimicrobial stewardship. The faculty will present two case studies and will solicit audience participation with a focus on antibiotic resistance and the importance of transition of care.
Chair: William Ford, MD, SFHM, Abington Jefferson Health, Abington, Penn.
Faculty: Mauricio Pinto, MD, St. David’s Round Rock Medical Center, Round Rock, Tex.; Sumeet Shetty, MD, MBA, FHM, Axel Health, Fort Meyers, Fla.
This program is supported by Nabriva Therapeutics, plc.
Register: NabrivaEvents@HCAGroup.com www.nabrivaevents.com/SHM/Symposium, or call 877-547-5640.
Direct Oral Anticoagulants (DOACs): Current Evidence for Extended VTE Prophylaxis in Medically Ill Patients and Reversal
Monday, April 9
7:30 – 9:30 p.m., Canary Room 3-4
Dinner provided at 7:30 p.m.
Overview: Patients hospitalized for an acute medical illness are at an increased risk for venous thromboembolism (VTE). With increasingly shortened hospital stays, acutely ill hospitalized patients are at an increased risk of developing VTE both in the hospital and after discharge. Outpatient VTE episodes often occur within 30 days of hospital discharge and fewer than half of those discharged patients receive VTE prophylaxis. Therefore, it is important for clinicians to be able to risk-stratify patients and provide extended prophylaxis for medical patients at increased risk for VTE.
This symposium will discuss the risk factors and burden of VTE and review ACCP guideline recommendations for VTE prophylaxis in acutely ill hospitalized medical patients. Faculty will assess the safety and efficacy of direct oral anticoagulants (DOACs) for extended VTE prophylaxis, explain the stratification of VTE and bleeding risk, as well as the process for devising evidence-based antithrombotic regimens. The presentation also will include an outline of current and emerging options for reversal of direct oral anticoagulants.
Learning objectives:
- Outline the risk factors and burden of VTE in medically ill patients post hospitalization.
- Review ACCP and ASH guideline recommendations for VTE prophylaxis in acutely ill hospitalized medical patients.
- Assess the safety and efficacy of DOACs for extended VTE prophylaxis in medically ill patients.
- Devise evidence-based antithrombotic regimens for medically ill patients taking into consideration patient-specific factors that impact VTE and bleeding risk
- Outline current and emerging options for reversal of DOACs
Faculty: Amir K. Jaffer, MD, MBA, chief medical officer, New York Presbyterian Queens Hospital, New York; Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC, professor of medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, system director – anticoagulation and clinical thrombosis services, Northwell Health at Lenox Hill Hospital, New York, NY; and Alan Jacobson, MD, FACC, assistant professor of medicine, Loma Linda University School of Medicine, director of anticoagulation services, Loma Linda VA Medical Center, Calif.
Target audience: Hospitalists, internists, nurse practitioners (NPs), physician assistants (PAs) who practice in a hospital setting.
Credit designation: Horizon CME designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the providership of Horizon CME. Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
ABIM MOC statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.
Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Supporter statement: This activity is supported by an independent educational grant from Portola Pharmaceuticals.
Register: http://bit.ly/2EoP1tb